# OCSTAMP

## Overview
OCSTAMP (osteoclast stimulatory transmembrane protein) is a gene that encodes a multi-pass transmembrane protein crucial for the fusion of pre-osteoclasts into multinucleated osteoclasts, which are essential for bone resorption and remodeling. The protein, also referred to as OC-STAMP, is characterized by a 6-transmembrane domain structure and is primarily localized to the plasma membrane, facilitating its role in cell-cell fusion processes (Witwicka2015Studies). OC-STAMP is regulated by the transcription factor NFATc1 and is upregulated by RANKL, a key factor in osteoclast differentiation (Kim2010Molecules; Miyamoto2012Osteoclast). Beyond its role in osteoclastogenesis, OC-STAMP also influences macrophage polarization, promoting an anti-inflammatory phenotype (Yuan2017Osteoclast). Its interactions with proteins such as DC-STAMP and CD9 are vital for osteoclast fusion, highlighting its significance in bone health and potential implications in bone-related disorders (Ishii2018OC‐STAMP; Miyamoto2012Osteoclast).

## Structure
OCSTAMP (osteoclast stimulatory transmembrane protein) is a multi-pass transmembrane protein essential for the fusion of pre-osteoclasts into multinucleated osteoclasts. It is predicted to have a 6-transmembrane domain structure with both N- and C-termini located intracellularly (Witwicka2015Studies). The protein includes a conserved N-linked glycosylation site at position N162 on an extracellular loop, which is important for protein stability, although not essential for its function in osteoclast fusion (Witwicka2015Studies). This glycosylation site is conserved across various species, indicating its functional significance (Witwicka2015Studies).

The primary structure of OCSTAMP is encoded by three exons, with exon 1 encoding the first 14 amino acids, exon 2 encoding amino acids 15-348, and exon 3 encoding the remainder (Witwicka2015Studies). The protein's topology suggests that it is primarily localized to the plasma membrane, consistent with its role in cell-cell fusion processes (Witwicka2015Studies). While specific details on secondary, tertiary, and quaternary structures are not provided, the transmembrane nature and glycosylation suggest a complex folding necessary for its function in osteoclast fusion. The protein's expression and function are regulated by the transcription factor NFATc1, which binds to its promoter region (Miyamoto2012Osteoclast).

## Function
OCSTAMP (osteoclast stimulatory transmembrane protein) is integral to the process of osteoclastogenesis, particularly in the fusion of pre-osteoclasts into mature, multinucleated osteoclasts. This protein is crucial for bone resorption, a process essential for bone remodeling and homeostasis. OCSTAMP is specifically required for the cell-cell fusion of osteoclasts, as its deficiency leads to the formation of mononuclear osteoclasts with significantly reduced bone-resorbing activity, although these cells can still form ruffled borders and sealing zones (Witwicka2015Studies; Miyamoto2012Osteoclast).

OCSTAMP is expressed in various tissues and is upregulated by RANKL (Receptor Activator of Nuclear Factor Kappa-Β Ligand), a key factor in osteoclast differentiation. Its expression is regulated by several signaling pathways, including PKCb, p38, JNK, NF-jB, and Akt, which are crucial for osteoclast differentiation and function (Kim2010Molecules). OCSTAMP also plays a role in macrophage polarization, promoting an anti-inflammatory M2 phenotype and inhibiting the pro-inflammatory M1 state, potentially through the STAT6-STAT1 signaling axis (Yuan2017Osteoclast). This dual role in osteoclast fusion and macrophage polarization underscores its importance in maintaining tissue homeostasis and regulating inflammatory responses.

## Clinical Significance
Mutations or alterations in the expression of the OCSTAMP gene can significantly impact bone health and are potentially linked to various bone-related conditions. OCSTAMP is crucial for the fusion of pre-osteoclasts into multinucleated osteoclasts, which are essential for effective bone resorption. Deficiency or inhibition of OCSTAMP results in impaired osteoclast fusion, leading to the formation of mononuclear osteoclasts with reduced bone resorption activity (Witwicka2015Studies; Miyamoto2012Osteoclast). This impaired fusion process can affect bone density and may contribute to conditions such as osteopetrosis, characterized by increased bone mass due to defective osteoclast function (Yang2007Osteoclast).

OCSTAMP expression is also responsive to inflammatory signals, suggesting a role in bone loss associated with inflammatory conditions (Yang2007Osteoclast). Although specific diseases directly linked to OCSTAMP mutations are not detailed, its role in osteoclast differentiation and response to inflammation indicates a potential connection to disorders involving abnormal bone remodeling and immune responses (Miyamoto2012Osteoclast). The cooperative function of OCSTAMP with DC-STAMP in osteoclast and foreign body giant cell fusion further underscores its importance in maintaining normal bone and immune system functions (Miyamoto2012Osteoclast).

## Interactions
OCSTAMP (osteoclast stimulatory transmembrane protein) is involved in several interactions crucial for osteoclast fusion and function. It cooperates with DC-STAMP (dendritic cell-specific transmembrane protein) to facilitate cell-cell fusion in osteoclasts and foreign body giant cells (FBGCs). This cooperation is essential, as mixed cultures of OC-STAMP-deficient and DC-STAMP-deficient cells do not induce fusion, indicating that both proteins are necessary for this process (Miyamoto2012Osteoclast).

OCSTAMP also interacts with CD9, a fusogen that is upregulated in the presence of OCSTAMP. This interaction is significant in promoting osteoclast fusion and bone resorption, particularly in the context of periodontitis. Anti-OC-STAMP monoclonal antibodies have been shown to down-regulate CD9 expression in RANKL-stimulated osteoclast precursors, suggesting a specific interaction between OCSTAMP and CD9 in osteoclastogenesis (Ishii2018OC‐STAMP).

Additionally, OCSTAMP is involved in the regulation of ATP6V0d2 expression, which is necessary for osteoclast fusion. This regulation highlights its role in the molecular mechanisms underlying osteoclast fusion and bone resorption (Ishii2018OC‐STAMP).


## References


[1. (Yang2007Osteoclast) Meiheng Yang, Mark J. Birnbaum, Carole A. MacKay, April Mason‐Savas, Benjamin Thompson, and Paul R. Odgren. Osteoclast stimulatory transmembrane protein (oc‐stamp), a novel protein induced by rankl that promotes osteoclast differentiation. Journal of Cellular Physiology, 215(2):497–505, December 2007. URL: http://dx.doi.org/10.1002/jcp.21331, doi:10.1002/jcp.21331. This article has 111 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcp.21331)

[2. (Miyamoto2012Osteoclast) Hiroya Miyamoto, Takayuki Suzuki, Yoshiteru Miyauchi, Ryotaro Iwasaki, Tami Kobayashi, Yuiko Sato, Kana Miyamoto, Hiroko Hoshi, Kazuaki Hashimoto, Shigeyuki Yoshida, Wu Hao, Tomoaki Mori, Hiroya Kanagawa, Eri Katsuyama, Atsuhiro Fujie, Hideo Morioka, Morio Matsumoto, Kazuhiro Chiba, Motohiro Takeya, Yoshiaki Toyama, and Takeshi Miyamoto. Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cells. Journal of Bone and Mineral Research, 27(6):1289–1297, February 2012. URL: http://dx.doi.org/10.1002/jbmr.1575, doi:10.1002/jbmr.1575. This article has 141 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/jbmr.1575)

[3. (Witwicka2015Studies) Hanna Witwicka, Sung-Yong Hwang, Pablo Reyes-Gutierrez, Hong Jia, Paul E. Odgren, Leah Rae Donahue, Mark J. Birnbaum, and Paul R. Odgren. Studies of oc-stamp in osteoclast fusion: a new knockout mouse model, rescue of cell fusion, and transmembrane topology. PLOS ONE, 10(6):e0128275, June 2015. URL: http://dx.doi.org/10.1371/journal.pone.0128275, doi:10.1371/journal.pone.0128275. This article has 61 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0128275)

[4. (Ishii2018OC‐STAMP) Takenobu Ishii, Montserrat Ruiz‐Torruella, Atsushi Ikeda, Satoru Shindo, Alexandru Movila, Hani Mawardi, Abdullah Albassam, Rayyan A. Kayal, Ayman A. Al‐Dharrab, Kenji Egashira, Wichaya Wisitrasameewong, Kenta Yamamoto, Abdulghani I. Mira, Kenji Sueishi, Xiaozhe Han, Martin A. Taubman, Takeshi Miyamoto, and Toshihisa Kawai. Oc‐stamp promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up‐regulation of permissive fusogen cd9. The FASEB Journal, 32(7):4016–4030, March 2018. URL: http://dx.doi.org/10.1096/fj.201701424r, doi:10.1096/fj.201701424r. This article has 29 citations.](https://doi.org/10.1096/fj.201701424r)

[5. (Yuan2017Osteoclast) Huimin Yuan, Jiangping He, Guangya Zhang, Dandan Zhang, Xiangxin Kong, and Fengling Chen. Osteoclast stimulatory transmembrane protein induces a phenotypic switch in macrophage polarization suppressing an m1 pro-inflammatory state. Acta Biochimica et Biophysica Sinica, 49(10):935–944, October 2017. URL: http://dx.doi.org/10.1093/abbs/gmx092, doi:10.1093/abbs/gmx092. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/abbs/gmx092)

[6. (Kim2010Molecules) Myung Hee Kim, Mikyung Park, Seung-hwa Baek, Hye Joo Kim, and Seong Hwan Kim. Molecules and signaling pathways involved in the expression of oc-stamp during osteoclastogenesis. Amino Acids, 40(5):1447–1459, September 2010. URL: http://dx.doi.org/10.1007/s00726-010-0755-4, doi:10.1007/s00726-010-0755-4. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00726-010-0755-4)